Document is current
Any future updates will be listed below
-
Authors
Pastorello, Anne https://orcid.org/0000-0001-9675-0866
Vuillermoz, Cécile
Meyer, Laurence https://orcid.org/0000-0001-5707-2062
Davisse-Paturet, Camille
Coste, Joël
Bajos, Nathalie
Lambotte, Olivier
Noël, Nicolas
Kose, Junko
Warszawski, Josiane https://orcid.org/0000-0001-8590-7952
Rouquette, Alexandra https://orcid.org/0000-0002-2473-1719
,
Bagein, Guillaume
Costemalle, Vianney
Counil, Emilie
Deroyon, Thomas
Jusot, Florence
Raynaud, Philippe
Pailhé, Ariane
Rahib, Delphine
Sillard, Patrick
Spire, Alexis
-
Funding
Funding for this research was provided by:
INSERM ; DREES; Région Ile-de-France ; French Ministry for Research; Paris-Saclay University; European Union’s Horizon 2020 research and innovation program
- License Information
-
More Information
Article History
Received: 5 December 2025
Accepted: 23 March 2026
First Online: 14 April 2026
Declarations
:
: The EpiCov study received approval from the Comité de Protection des Personnes Sud Méditerranée III (ref: MLD/MFI/AR205138) and the Commission Nationale Informatique et Libertés in April 2020 (2020-A01191-38). All participants or their legally authorized representatives provided informed consent to participate in this study.
: Not applicable.
: The authors declare no competing interests.
